CNIO scientists discovers a combination therapy for aggressive brain tumors

(Centro Nacional de Investigaciones Oncol ó gicas (CNIO)) * The researchers conducted an in-depth study of resistance to temozolomide, the first-line treatment for glioblastoma, to which many patients cease to respond over time* The combination of temozolomide and dianhydrogalactitol acts synergistically, overcomes this resistance and increases survival in mice with brain tumours* Treatments for glioblastoma have not improved in the last 20 years. The authors argue for the need to translate these results into clinical trials to study whether this combination therapy is also effective in patients with this disease
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news